Transaction Highlights

Client: Novolex

Type: M&A

Value: US $6.7 billion

RBC's role: Financial Advisor


Pactiv Evergreen announced that it has entered into a definitive agreement to merge with Apollo portfolio company Novolex, in an all-cash transaction. Pactiv and Novolex are highly complementary businesses that will offer a broad product platform, establishing one of the most diverse substrate offerings in the packaging industry.

RBC Capital Markets served as Financial Advisor to Novolex on the transaction.

Stay Informed

Get the latest insights from RBC Capital Markets delivered to your inbox.